Skip to main content
PLOS One logoLink to PLOS One
. 2021 May 12;16(5):e0250742. doi: 10.1371/journal.pone.0250742

Cerebrospinal fluid dynamics correlate with neurogenic claudication in lumbar spinal stenosis

Hyun-Ji Kim 1, Hakseung Kim 1, Young-Tak Kim 1, Chul-Ho Sohn 2, Keewon Kim 3,*, Dong-Joo Kim 1,4,*
Editor: Michael C Burger5
PMCID: PMC8115821  PMID: 33979373

Abstract

Neurogenic claudication is a typical manifestation of lumbar spinal stenosis (LSS). However, its pathophysiology is still unclear. The severity of clinical symptoms has been shown not to correlate with the degree of structural stenosis. Altered cerebrospinal fluid (CSF) flow has been suggested as one of the causative factors of LSS. The objectives of this study were to compare CSF dynamics at the lumbosacral level between patients with LSS and healthy controls and to investigate whether CSF dynamics parameters explain symptom severity in LSS. Phase-contrast magnetic resonance imaging (PC-MRI) was conducted to measure CSF dynamics in 18 healthy controls and 9 patients with LSS. Cephalic peak, caudal peak, and peak-to-peak CSF velocities were evaluated at the lumbosacral level in the patients and controls. The power of CSF dynamics parameters to predict symptom severity was determined using a linear regression analysis adjusted for demographic and structural variables. Significantly attenuated CSF flow velocity was observed in the patients compared with the controls. The cephalic peak, caudal peak, and peak-to-peak velocities at the lumbar level were greater in the controls than in the patients (p<0.001). The predictive power increased most when the peak-to-peak velocity was added (adjusted R2 = 0.410) to the model with age, body mass index, and the minimum anterior-posterior diameter (adjusted R2 = 0.306), and the peak-to-peak velocity was the only statistically significant variable. CSF dynamics variables showed an association with the severity of LSS symptoms, independent of structural stenosis. PC-MRI can help to further our understanding of the pathophysiology of neurogenic claudication and support the diagnosis of LSS.

Introduction

Lumbar spinal stenosis (LSS) is a common degenerative disease characterized by a narrowed spinal canal in imaging and neurogenic claudication as a phenotype [1, 2]. Neurogenic claudication is characterized by unilateral or bilateral pain during walking, standing or lumbar extension [3]. Although LSS is highly prevalent and exhibits typical clinical manifestations, the pathophysiology of LSS remains unclear [4]. Mechanical nerve root compression has been proposed for the pathophysiology of neurogenic claudication. However, decompressive surgery to relieve stenosis does not always result in the effective relief of symptoms [5, 6]. Epidural steroid injections to relieve neural inflammation, which is another proposed pathogenesis of LSS, do not exhibit significant efficacy for relieving the pain of patients with LSS [3, 7]. Neurogenic claudication appears to be induced by vascular insufficiency [1, 8, 9]. Nonetheless, the administration of limaprost, a prostaglandin E1 analogue, to treat venous congestion also does not always yield satisfactory results [10]. LSS is clinically diagnosed based on a combination of the patient’s clinical history, physical examination, and radiologic findings; a single pathognomonic test is not available because knowledge regarding the pathophysiology of this condition is insufficient. A narrowed spinal canal is a common radiological finding on spinal imaging of LSS patients; however, the extent of stenosis does not predict or explain the symptoms [11]. Structural abnormalities measured using conventional magnetic resonance imaging (MRI) or computed tomography do not always correlate with the functional state of patients with LSS [12], indicating that structural compression alone is not sufficient to explain symptom development.

Cerebrospinal fluid (CSF) dynamics have been proposed to be associated with neurogenic claudication [13]. Altered CSF dynamics in the brains of patients with hydrocephalus cause neurological deficits in the brain [14]. Likewise, altered CSF dynamics in the spine may also affect neural tissue in the spinal cord or nerve roots. Indeed, in LSS, patients with multilevel stenosis are more prone to develop neurogenic claudication than patients with single-level stenosis; dynamic rather than static structural components may contribute to the development of phenotypes [1, 15]. Changes in hydrostatic pressure caused by walking or changes in posture have been shown to be associated with neurogenic claudication [13, 16]. Forward bending may relieve claudication by increasing the spinal canal area, hence improving CSF circulation [1, 11, 13, 16]. A few previous studies have investigated the hydrodynamic parameters of CSF in the spinal canal of patients with spinal stenosis [13, 17]. In our pilot study, CSF flow was attenuated at the lumbosacral level in patients with LSS who experienced neurogenic claudication compared to normal healthy controls [18]. These various observations suggest that CSF dynamics may be associated with the pathophysiology of LSS.

The aim of this study was to examine the hypothesis that CSF dynamics independently contribute to the development of neurogenic claudication in LSS. For that purpose, we quantitatively measured CSF dynamics at the lumbosacral level using phase-contrast magnetic resonance imaging (PC-MRI) in patients with LSS and healthy controls and compared their hydrodynamic parameters. Furthermore, the predictive power of CSF dynamic variables for LSS symptom severity was evaluated in addition to epidemiologic and structural variables.

Materials and methods

Subjects

This level-3 investigational, observational study compared the CSF dynamics of patients with LSS and healthy controls. The study was approved by the institutional ethics committee of Seoul National University Hospital (Seoul, South Korea), and written informed consent was obtained from each subject (IRB number: H-1203-088-402). Patients with LSS were recruited from the outpatient clinic of a tertiary hospital and met the following criteria: (a) symptoms were experienced for more than 3 months; (b) claudication was provoked after less than 30 minutes of walking; and (c) spinal canal stenosis with a minimal anterior-posterior (AP) diameter less than 10 mm was confirmed by lateral plain radiology. The exclusion criteria were as follows: (a) systemic peripheral neuropathy, peripheral vascular disease with vascular claudication, or a history of lumbar or brain surgery based on the patient’s medical history; (b) segmental instability, which was defined as a > 4-mm translation of the sagittal plane or > 10° angular motion [19] based on dynamic plain radiograph, structural stenosis due to nondegenerative causes such as fractures or tumors, and foraminal stenosis that could explain the symptoms based on imaging studies; (c) concomitant myelopathy; or (d) a poor general medical condition that impeded gait function. Twelve LSS patients were initially enrolled in this study based on these inclusion and exclusion criteria. Subsequently, three subjects were excluded during the imaging analysis because the spinal canal was overlapped by aliasing artifacts from the kidney vessels. Thus, the LSS group consisted of nine patients, and the control group included eighteen healthy volunteers.

Demographic variables were obtained, including age, sex, and body mass index (BMI), which was calculated based on height and weight. A subjective assessment of symptom severity was conducted by recording the patient history and performing a physical examination. Patient history included information on the duration, characteristics, and distribution of symptoms and aggravating or relieving factors. Physical examination included the straight leg raise test, prone instability test, and neurological examinations, such as the manual muscle strength test, sensory examination, and deep tendon reflex. The ankle brachial index was assessed using a cuff manometer to exclude vascular claudication.

To evaluate symptom severity, all subjects completed the Oswestry disability index (scores range from 0 to 100 points) [20]. In this study, LSS symptom severity was evaluated based on ‘claudication distance’, which was defined as the distance one could walk without rest until restricted by the development of neurogenic claudication. Per the Oswestry disability index scale, the claudication distance was scored as 1 to 5 for walking distances less than 100 m, 100–499 m, 500–999 m, greater than 1000 m, and no claudication, respectively. A detailed description of the characteristics of the subjects is presented below (Table 1).

Table 1. Baseline characteristics.

Healthy controls (n = 18) Patients with LSS (n = 9) p-value*
Males, n (%) 9 (50) 4 (44.4) 0.79
Age, years 56 (47–61.5) 68 (57–75) 0.015
Body mass index, kg/m2 24.2 (21.5–26.8) 26.9 (25.6–29.8) <0.001
Oswestry disability index 0 (0–1.25) 18 (14–20) <0.001
Claudication distance score, n (%) <0.001
 I 0 (0) 1 (11.1)
 II 0 (0) 3 (33.3)
 III 0 (0) 4 (44.4)
 IV 0 (0) 1 (11.1)
 V 18 (100) 0 (0)

* Categorical and continuous variables were assessed using the chi-square test and the Mann-Whitney U-test (t-test), respectively.

Data represented as median (interquartile range).

Data acquisition

The MRI examinations were performed using a 3.0 Tesla MR system (Siemens, Magnetom Trio, Erlangen, Germany). The same PC-MRI protocol was used for all subjects (TR/TE = 28.45 ms/9.47 ms, flip angle = 15°, FOV = 320 mm, voxel size = 1×1×5 mm3, slice thickness = 5 mm, 25% oversampling of the AP phase-encoding direction, bandwidth = 195 Hz/pixel, foothead single-direction velocity encoding, and generalized autocalibrating partially parallel acquisition with an acceleration factor of 2). T2-weighted images were acquired in the sagittal plane to determine structural stenosis.

CSF flow velocities were quantitatively evaluated at the level of the mid-vertebral body of the second lumbar vertebra (L2) and the first sacral vertebra (S1) using axial plane PC-MRI (Fig 1; and see Video in S1 Video, which illustrates the CSF flow). The following parameters were measured: the scan time was set based on the subject’s heart rate averaged over 8 minutes (range 4–9 minutes), TR/TE = 34.60 ms/11.0 ms, flip angle = 15°, FOV = 320 mm, voxel size = 1.3×1×7 mm3, slice thickness = 7 mm, 60% oversampling of the AP phase-encoding direction, bandwidth = 130 Hz/pixel, through-plane single-direction velocity encoding, and no generalized autocalibrating partially parallel acquisition. Retrospective peripheral gating allowed 25 data points to be acquired over the entire cardiac cycle. A 4 cm/s velocity-encoding parameter was applied in all cases; velocity-encoding was determined to be 4 cm/s because the velocity of the CSF vertical flow at the lumbar or sacral level was observed to range between -2 cm/s and 2 cm/s based on a pilot study [18].

Fig 1. Observations of CSF dynamics in three typical cases: A healthy control subject (A), a healthy control subject with a narrow canal (B), and a patient with lumbar spinal stenosis (C).

Fig 1

The 1st row depicts the T2-weighted MR images in the midsagittal plane, and the 2nd to 4th rows show the phase images in the midsagittal plane, L2 axial plane, and S1 axial plane, respectively. The 5th row shows the CSF flow velocity at the L2 (black line) and S1 (gray line) levels during one cardiac cycle. Subject A (a 56-year-old female) had no LSS symptoms and a minimum anterior-posterior diameter (min AP) of 10.38 mm at the L4/5 level. Subject B (a 61-year-old female) had no LSS symptoms but showed a narrow spinal canal with a min AP of 6.44 mm at the L4/5 level. Subject C (a 68-year-old male) had experienced neurogenic claudication for 1 year and showed multilevel stenosis at the L2/3, L3/4, and L4/5 levels with a min AP of 6.09 mm at the L4/5 level. A positive value indicates cephalic CSF flow, and a negative value denotes caudal CSF flow. The red arrowhead indicates CSF flow, and the red circle indicates the selected region of interest (ROI).

Data analysis

The AP diameters of the canal were measured from the L1/2 to the L5/S1 mid-disc level using the mid-sagittal T2-weighted image. To indicate the severity of structural stenosis, the smallest AP diameter was designated as the minimum AP diameter (min AP). Region of interest (ROI) segmentation of the spinal canal was manually performed to measure CSF dynamics within the ventral part of the dural sac. An ROI was placed within the ventral part of the dural sac, showing an evident change in CSF flow on the axial phase images. Next, the location of the ROI was adjusted by excluding the dura mater or rootlets. The size of the rectangular ROI placed on the axial images was 0.3×0.3 cm2. CSF flow velocity values were acquired for each of the 25-time frames over the entire cardiac cycle. The CSF flow velocity reveals the cephalic and caudal flow phases within one cardiac cycle: a positive velocity indicates the CSF flow upward along the axis (cephalic flow), and a negative velocity indicates the CSF flow downward along the axis (caudal flow). Three variables with simple but large descriptive power were calculated to represent CSF hydrodynamics: the maximum positive and minimum negative velocities were defined by the cephalic peak velocity and caudal peak velocity, respectively, and the peak-to-peak velocity was defined as the difference between the cephalic and caudal peak velocities.

Statistical analysis

All statistical analyses were conducted with SPSS 25.0 (IBM Corp., Chicago, Illinois, USA). First, all the data were tested for normality using the Shapiro-Wilk test.

Parametric tests (t-test) were used to compare the normally distributed variables (BMI, min AP, cephalic peak velocity, caudal peak velocity, and peak-to-peak velocity), and nonparametric tests (Mann-Whitney U-test) were used to compare the categorical or discrete variables (sex, age, and claudication distance score) between the patients with LSS and the controls. The categorical variables, sex and claudication distance score, were examined using a chi-square test. A repeated-measures ANOVA was conducted to assess the variability in velocity at the sacral level during one cardiac cycle.

Associations of epidemiological, structural, and CSF dynamics variables with symptom severity were explored by performing a univariate linear regression analysis using the claudication distance score as the dependent variable. A multivariate linear regression analysis was performed by adding or deleting epidemiological, structural, and hydrodynamic variables in multivariate models to determine whether the CSF hydrodynamic parameter contributed to symptom severity. Model 1 included the epidemiological variables, and structural variables were added to Model 1 to produce Model 2. Model 3 substituted CSF dynamics variables for the structural variables in Model 2. Model 4 included all the epidemiologic, structural, and CSF dynamics variables. The variables in the multivariate models were those with a p-value <0.10 in the univariate analysis and were evaluated for the collinearity effect using the variance inflation factor. The adjusted R-square (R2) value was calculated to evaluate the predictive power of each model. Statistical significance was set to a p-value of less than 0.05; a Bonferroni correction (p < 0.017 (0.05/3)) was applied to adjust for multiple pairwise comparisons between 3 groups.

Results

CSF velocity in patients with lumbar spinal stenosis compared with healthy controls

Considerable differences in CSF velocity at the lumbar level were observed between the patients with LSS and the healthy controls (Table 2 and Fig 2A). The patients with LSS showed significantly attenuated CSF velocities compared with the healthy controls (Table 2). At the sacral level, the maximum CSF velocity tended to be lower in the patients with LSS (healthy controls vs. patients with LSS, median (interquartile range): 0.6 (0.5–0.7) vs. 0.5 (0.4–0.6) cm/s, p = 0.03), but the velocity throughout the entire cardiac cycle was not significantly different from that of the healthy controls (p = 0.62; Fig 2B).

Table 2. CSF flow velocity (cm/s) at L2 in the healthy controls and the patients with LSS.

Healthy controls Patients with LSS p-value*
Cephalic peak velocity 0.8 (0.5–1.2) 0.2 (0.2–0.3) <0.001
Caudal peak velocity -1.3 (-2.0–-0.9) -0.4 (-0.5–-0.3) <0.001
Peak-to-peak velocity 1.9 (1.5–3.2) 0.6 (0.5–0.7) <0.001

* Based on the t-test.

Data represented as median (interquartile range).

Fig 2. Averaged CSF flow curves at the lumbosacral level over one cardiac cycle for patients with LSS and healthy controls.

Fig 2

CSF dynamics of a patient with LSS (pink line) and a healthy control (dark blue line) at L2 (A) and S1 (B). The lines represent the mean values and the shaded areas denote the 95% confidence interval.

Association of individual variables with symptom severity

A univariate linear regression analysis was conducted to determine the correlations between LSS symptom severity and demographic, structural, and CSF dynamics parameters (Table 3). Except for sex, all the variables were significantly correlated with symptom severity as determined by claudication distance score: the claudication distance score decreased (more severe symptom) significantly with increasing (milder symptom) age, BMI, and caudal peak velocity and increased in subjects with a greater min AP, cephalic peak velocity, and peak-to-peak velocity.

Table 3. Univariate linear regression analysis to explain the claudication distance score.

B (95% CI) Adjusted R2 p-value
Sex (male = 0, female = 1) -0.385 (-1.401–0.632) -0.015 0.44
Age -0.043 (-0.074–-0.012) 0.214 0.009
Body mass index -0.155 (-0.290–-0.019) 0.149 0.027
Minimum AP diameter 0.222 (0.044–0.400) 0.178 0.016
Cephalic peak velocity 1.556 (0.678–2.434) 0.321 0.001
Caudal peak velocity -1.036 (-1.586–-0.486) 0.351 0.001
Peak-to-peak velocity 0.653 (0.311–0.995) 0.358 0.001

Bolded: statistically significant.

Minimum AP diameter: minimum anterior-posterior diameter.

Predictive model for LSS symptom severity

Multivariate linear regression analyses were performed to determine whether CSF dynamics parameters independently contributed to symptom severity (Table 4). All the models were adjusted for age, BMI, min AP, and CSF dynamics variables. Peak-to-peak velocity, which was the CSF dynamics variable that exhibited the strongest R2 value in univariate linear regression among the CSF dynamics parameters, was used as the CSF dynamics variable. Model 1, which included age and BMI, explained 26.2% of the variance in symptom severity. When the degree of stenosis was added to Model 1, the explanation of the variance increased to 30.6% (Model 2: age, BMI, and min AP). When the structural variables in Model 2 were replaced with the CSF hydrodynamics (Model 3: age, BMI, and peak-to-peak velocity), the descriptive power was found to increase markedly (adjusted R2 = 0.393). Model 4, which included age, BMI, min AP, and peak-to-peak velocity, showed the highest goodness-of-fit and had peak-to-peak velocity as the only significant variable (adjusted R2 = 0.410).

Table 4. Multivariate linear regression analysis to explain the claudication distance score.

B (95% CI) p-value Adjusted R2
Model 1 (demographic variables)
 Age -0.034 (-0.066–-0.002) 0.038 0.262
 Body mass index -0.105 (-0.240–0.029) 0.12
Model 2 (demographic + structural variables)
 Age -0.032(-0.063–-0.001) 0.045 0.306
 Body mass index -0.058(-0.202–0.087) 0.42
 Minimum AP diameter 0.144(-0.043–0.330) 0.13
Model 3 (demographic + CSF dynamics variables)
 Age -0.015(-0.048–0.018) 0.37 0.393
 Body mass index -0.082(-0.206–0.042) 0.19
 Peak-to-peak velocity 0.482(0.080–0.883) 0.021
Model 4 (demographic + structural + CSF dynamics variables)
 Age -0.015(-0.048–0.018) 0.35 0.410
 Body mass index -0.047(-0.182–0.087) 0.47
 Minimum AP diameter 0.11(-0.066–0.285) 0.21
 Peak-to-peak velocity 0.437(0.034–0.840) 0.035

Bolded: statistically significant.

Minimum AP diameter: minimum anterior-posterior diameter.

Predictive model for LSS symptom severity in elderly subjects

Further linear regression analysis was conducted with closer age matching by excluding the younger healthy controls from all subjects (n = 23, mean age (range): 61.7 (49–76) years; S1 File and Table 5). The predictive power was increased by the addition of the CSF dynamics parameter (model 3 [age, BMI, and peak-to-peak velocity], adjusted R2 = 0.623; model 4 [age, BMI, min AP, and peak-to-peak velocity], adjusted R2 = 0.609). Age, which showed no significance in the model for all subjects, was significantly correlated with the claudication distance score in the model for aged subjects. Nevertheless, the predictive power of all the models showed improvements compared to the models analyzed in the all-subjects group (adjusted R2 of the model with all subjects vs. elderly subjects, model 1: 0.262 vs. 0.359; model 2: 0.306 vs. 0.371; model 3: 0.393 vs. 0.623; model 4: 0.410 vs. 0.609).

Table 5. Multivariate linear regression analysis to explain the claudication distance score in the elderly subjects.

B (95% CI) p-value Adjusted R2
Model A (demographic variables)
 Age -0.087 (-0.145–-0.028) 0.006 0.359
 Body mass index -0.144 (-0.285–-0.003) 0.045
Model B (demographic + structural variables)
 Age -0.073 (-0.136–-0.011) 0.024 0.371
 Body mass index -0.084 (-0.261–0.092) 0.33
 Minimum AP diameter 0.146 (-0.115–0.406) 0.26
Model C (demographic + CSF dynamics variables)
 Age -0.076 (-0.121–-0.030) 0.002 0.623
 Body mass index -0.113 (-0.222–-0.003) 0.045
 Peak-to-peak velocity 0.672 (0.309–1.036) 0.001
Model D (demographic + structural + CSF dynamics variables)
 Age -0.071 (-0.120–-0.021) 0.008 0.609
 Body mass index -0.090 (-0.230–0.049) 0.19
 Minimum AP diameter 0.0580 (-0.155–0.270) 0.58
 Peak-to-peak velocity 0.647 (0.263–1.030) 0.002

Bolded: statistically significant.

Minimum AP diameter: minimum anterior-posterior diameter.

Discussion

This study was conducted to test whether CSF dynamics explained the severity of neurogenic claudication in LSS using PC-MRI. In the comparison of patients with LSS and healthy controls, greater CSF flow velocities were found in the healthy controls and the difference was particularly significant at the lumbar level. CSF dynamics parameters predicted the severity of LSS symptoms independent of epidemiological or structural parameters; the predictive power was improved by the addition of a CSF dynamics parameter.

Although CSF dynamics predict LSS symptoms, it remains possible that CSF dynamics are secondary to the reduced spinal canal area. We evaluated the association between CSF dynamics and minimum canal diameter. Except for caudal peak velocity (r = -0.394, p = 0.042), CSF dynamics variables, i.e., cephalic peak velocity and peak-to-peak velocity, had no correlation with the severity of stenosis (Fig 3). Furthermore, when we measured the cross-sectional area (CSA) at the lumbar mid-vertebral level on the axial images, the CSA in the LSS patients was significantly lower than that in the healthy controls (healthy controls vs. patients with LSS, median (interquartile range): 222.5 (195.0–255.3) vs. 180.0 (152.5–206.5) mm2, p = 0.008). However, none of the CSF dynamics variables were correlated with the CSA (S1 Fig).

Fig 3. Scatter plots of the min AP versus CSF dynamics variables.

Fig 3

Comparison of the min AP with the cephalic peak velocity (A), caudal peak velocity (B), and peak-to-peak velocity (C). Min AP = minimum anterior-posterior diameter.

Another possible confounder that may entail the correlation between attenuated CSF dynamics and symptom severity is age. The age distribution in this study was uneven and could lead to biased results. To compensate for the uneven distribution of age, the healthy controls were divided into younger and older groups, and the CSF dynamics variables were compared between the subgroups (younger controls vs. older controls/younger controls vs. LSS patients/older controls vs. LSS patients). The CSF velocities measured at the lumbar level in the older control group tended to be lower than those in the younger control group, without statistical significance; however, those variables were remarkably decreased in the LSS patient group compared to both the younger and older controls (Fig 4 and Table 6). The reduced CSF dynamics at the lumbar level might be regarded as a specific observation in patients with LSS with neurogenic claudication. Nevertheless, further works should be conducted with a larger population to investigate the effects of age on the attenuation of CSF dynamics.

Fig 4. The influence of age on the CSF flow was considered by separately comparing older (> 50 years old, light blue line) and younger (< 30 years old, blue line) healthy controls at L2 (A) and S1 (B).

Fig 4

The lines represent the mean values and the shaded areas denote the 95% confidence interval.

Table 6. CSF flow velocity (cm/s) in the young and old healthy controls and patients with LSS.

Healthy control p-value* Patients with LSS
Young (n = 4) Old (n = 14) (n = 9)
Age, years 26 (25–28) 58 (54–64) 68 (57–75)
Cephalic peak velocity 1.3 (1.0–1.8) 0.6 (0.5–1.1) 0.035 0.2 (0.2–0.3)
Caudal peak velocity -2.1 (-2.4 –-1.1) -1.2 (-1.6–-0.9) 0.16 -0.4 (-0.5–-0.3)
Peak-to-peak velocity 3.4 (2.2–4.2) 1.9 (1.4–2.6) 0.046 0.6 (0.5–0.7)

* Adjustment for multiple comparisons: Bonferroni.

Data represented as median (interquartile range).

CSF dynamics in the spine are determined both by pulse generation from the neurovasculature of the brain and by flow resistance in the spinal canal. The attenuation of CSF pulsation might have resulted from reduced compliance of the central nervous system rather than from structural stenosis of the spine based on the Monro-Kellie doctrine [21]. A previous study of CSF flow in the spinal canal reported that spinal CSF pulsations are caused mainly by intracranial pulsations [22]. CSF pulsation at the cervical or cranial level has also been shown to decrease with age in accordance with reduced compliance of the brain as a degenerative process [23]. Symptomatic lumbar spinal stenosis can be considered a degenerative condition involving both the lumbar vertebral structure and the compliance of the CSF space.

Several previous studies have explained how changes in CSF dynamics affect neurogenic symptoms in patients with LSS. In terms of the kinetics of CSF, the theory of stagnant anoxia suggests that an increase in CSF pressure may block radicular venous drainage, resulting in relative hypoxia or a reduction in metabolic exchange [24, 25]; however, attenuation of CSF pulsation would be related to the pressure gradient rather than the local pressure. Moreover, congested CSF circulation may disturb the supply of nutrients or oxygen to neural tissues [26]. During walking, the metabolic demands of the nerve root increase, while the oxygen or nutrient supply decreases [1], causing neurological claudication. In a previous pilot study, compared to normal healthy controls, patients with LSS who experienced neurogenic claudication showed attenuated CSF flow [18]. These changes may result in neurogenic claudication and explain how altered CSF dynamics contribute to neurological symptoms.

Although spinal imaging is considered the most informative examination for the diagnosis of LSS, its diagnostic value remains uncertain. In practical studies, there is a high prevalence of asymptomatic stenosis; approximately 20% of the elderly population exhibits asymptomatic spinal stenosis on spinal images [27, 28]. Nonetheless, an assessment of the status of CSF dynamics may improve the diagnostic accuracy of spinal imaging for LSS; for example, in the present study, the predictive power was increased when CSF dynamics variables were added to demographic and structural variables (Tables 4 and 5). In addition, when a logistic regression analysis was conducted to determine whether the addition of CSF dynamics parameters improved the ability to diagnose LSS, adding a CSF dynamics variable was more beneficial for predicting LSS than adding structural variables (chi-square value of model 1 [age, BMI]: 14.410, model 3 [age, BMI, peak-to-peak velocity] and 4 [age, BMI, min AP, peak-to-peak velocity]: 19.701, 1 degree of freedom; p < 0.001; Table in S2 File). Moreover, decompression of structural stenosis does not guarantee clinical improvement in patients with LSS [5], probably because LSS symptoms are not only caused by compression but are also affected by altered neurophysiology within the CSF space. Therefore, evaluating CSF flow may improve the diagnostic accuracy of spinal imaging for LSS and support decision-making regarding treatment for LSS.

In this study, postprocessing of the ROI segmentation has limitations in assessing the CSF flow at the lumbosacral level. The ROI was obtained manually from the small area placed within the ventral part of the dural sac. The CSF flow within the ROI could be different from the total CSF flow in the spinal canal. However, as the spinal cord ends and divides into rootlets in the lumbosacral spine, it is difficult to delineate the CSF space. Moreover, the CSF flow at the lumbosacral level is much attenuated compared with that at the cervical level; it is hard to determine the adequate threshold of the dural sac. A previous study proposed a method for semiautomated ROI segmentation at the C2-C3 level by creating a parametric image with subsequent application of a visually selected threshold [29]. Future studies may implement an automated segmentation method for CSF flow at the lumbosacral level with adequate validation.

Several limitations of this study should be noted. First, kinetic parameters, such as CSF pressure, could not be analyzed using PC-MRI. The CSF pressure may more directly affect neurological impairments in LSS than CSF kinematics. Second, MRI-based tests cannot be used to evaluate CSF dynamics in an active state, which would have revealed pathophysiology more directly. Third, the patient group did not represent LSS patients in general because the current study included only patients with central stenosis without instability or lateral (foraminal) stenosis to test the effect of CSF dynamics within the canal on LSS symptoms under more homogenous conditions. Fourth, due to the technical constraints of PC-MRI, the detailed parameters of fluid dynamics (e.g., turbulent flow) were not considered. Future studies that employ computational fluid dynamics could model the kinetic parameters using PC-MRI. CSF flow in the brain or at the cervical level should be assessed, which would allow pulse generation to be directly measured. Furthermore, four-dimensional PC-MRI, which can be used to quantify velocities in the horizontal plane, will provide detailed insights into fluid dynamics. The main limitation of this study is the small cohort size, which may limit its statistical power for obtaining a convincing conclusion. A sufficient sample size could not be calculated, mainly due to the lack of relevant literature. Future research should test the present study’s findings with larger sample sizes.

To conclude, attenuation of CSF flow at lumbar spine level is associated with development of neurogenic claudication in LSS, better than severity of structural stenosis. Evaluation of CSF dynamics using PC-MRI may help diagnose LSS in the clinic.

Supporting information

S1 Video. CSF flow in three typical cases: A healthy control subject (A), a healthy control subject with a narrow canal (B), and a patient with LSS (C).

(MP4)

S1 Fig. Scatter plots of the cross-sectional area versus CSF dynamics variables.

(DOCX)

S1 File. Univariate linear regression analysis to explain the claudication distance score in the elderly subjects.

(DOCX)

S2 File. -2 Log likelihood ratio test to determine the effect of factors on LSS.

(DOCX)

S3 File. ROC analysis of linear regression models to predict LSS.

(DOCX)

S1 Data. The relevant data about this manuscript.

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

HJK, YTK, HSK, DJK: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT, MSIT) [No. 2019R1A2C1003399, 2020R1C1C1006773]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Porter RW. Spinal stenosis and neurogenic claudication. Spine. 1996;21(17):2046–52. 10.1097/00007632-199609010-00024 [DOI] [PubMed] [Google Scholar]
  • 2.Paine K, Cauchoix J, Mcivor G, Willis WK. Lumbar spinal stenosis. Clin Orthop Relat Res. 1974;99:30–50. 10.1097/00003086-197403000-00004 [DOI] [PubMed] [Google Scholar]
  • 3.Katz JN, Harris MB. Lumbar spinal stenosis. N Engl J Med. 2008;358(8):818–25. 10.1056/NEJMcp0708097 [DOI] [PubMed] [Google Scholar]
  • 4.Watters WC, Baisden J, Gilbert TJ, Kreiner S, Resnick DK, Bono CM, et al. Degenerative lumbar spinal stenosis: an evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spinal stenosis. Spine J. 2008;8(2):305–10. 10.1016/j.spinee.2007.10.033 [DOI] [PubMed] [Google Scholar]
  • 5.Weinstein JN, Tosteson TD, Lurie JD, Tosteson A, Blood E, Herkowitz H, et al. Surgical versus non-operative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial (SPORT). Spine. 2010;35(14):1329. 10.1097/BRS.0b013e3181e0f04d [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kobayashi S, Kokubo Y, Uchida K, Yayama T, Takeno K, Negoro K, et al. Effect of lumbar nerve root compression on primary sensory neurons and their central branches: changes in the nociceptive neuropeptides substance P and somatostatin. Spine. 2005;30(3):276–82. 10.1097/01.brs.0000152377.72468.f4 [DOI] [PubMed] [Google Scholar]
  • 7.Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014;371(1):11–21. 10.1056/NEJMoa1313265 [DOI] [PubMed] [Google Scholar]
  • 8.Matsudaira K, Seichi A, Kunogi J, Yamazaki T, Kobayashi A, Anamizu Y, et al. The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. Spine. 2009;34(2):115–20. 10.1097/BRS.0b013e31818f924d [DOI] [PubMed] [Google Scholar]
  • 9.Kobayashi S, Baba H, Uchida K, Kokubo Y, Yayama T, Takeno K, et al. Blood circulation of cauda equina and nerve root. Clin Calcium. 2005;15(3):63–72. [PubMed] [Google Scholar]
  • 10.Yoshihara H. Prostaglandin E1 treatment for lumbar spinal canal stenosis: review of the literature. Pain Pract. 2016;16(2):245–56. 10.1111/papr.12272 [DOI] [PubMed] [Google Scholar]
  • 11.Amundsen T, Weber H, Lilleas F, Nordal HJ, Abdelnoor M, Magnaes B. Lumbar spinal stenosis. Clinical and radiologic features. Spine (Phila Pa 1976). 1995;20(10):1178–86. Epub 1995/05/15. 10.1097/00007632-199505150-00013 . [DOI] [PubMed] [Google Scholar]
  • 12.Alsaleh K, Ho D, Rosas-Arellano MP, Stewart TC, Gurr KR, Bailey CS. Radiographic assessment of degenerative lumbar spinal stenosis: is MRI superior to CT? Eur Spine J. 2017;26(2):362–7. Epub 2016/09/25. 10.1007/s00586-016-4724-9 . [DOI] [PubMed] [Google Scholar]
  • 13.Magnaes B. Clinical recording of pressure on the spinal cord and cauda equina: Part 2: Position changes in pressure on the cauda equina in central lumbar spinal stenosis. J Neurosurg. 1982;57(1):57–63. 10.3171/jns.1982.57.1.0057 [DOI] [PubMed] [Google Scholar]
  • 14.Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery. 2001;49(5):1166–86. 10.1097/00006123-200111000-00028 [DOI] [PubMed] [Google Scholar]
  • 15.Porter R, Ward D. Cauda equina dysfunction. The significance of two-level pathology. Spine. 1992;17(1):9–15. 10.1097/00007632-199201000-00002 [DOI] [PubMed] [Google Scholar]
  • 16.Takahashi K, Miyazaki T, Takino T, Matsui T, Tomita K. Epidural pressure measurements. Relationship between epidural pressure and posture in patients with lumbar spinal stenosis. Spine. 1995;20(6):650–3. 10.1097/00007632-199503150-00003 [DOI] [PubMed] [Google Scholar]
  • 17.Magnaes B. Clinical recording of pressure on the spinal cord and cauda equina: Part 1: The spinal block infusion test: method and clinical studies. J Neurosurg. 1982;57(1):48–56. 10.3171/jns.1982.57.1.0048 [DOI] [PubMed] [Google Scholar]
  • 18.Chun SW, Lee HJ, Nam KH, Sohn CH, Kim KD, Jeong EJ, et al. Cerebrospinal fluid dynamics at the lumbosacral level in patients with spinal stenosis: A pilot study. J Orthop Res. 2017;35(1):104–12. 10.1002/jor.23448 [DOI] [PubMed] [Google Scholar]
  • 19.Dupuis PR, Yong-Hing K, Cassidy JD, Kirkaldy-Willis WH. Radiologic diagnosis of degenerative lumbar spinal instability. Spine. 1985;10(3):262–76. 10.1097/00007632-198504000-00015 [DOI] [PubMed] [Google Scholar]
  • 20.Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25(22):2940–53. 10.1097/00007632-200011150-00017 [DOI] [PubMed] [Google Scholar]
  • 21.Czosnyka M, Czosnyka ZH, Whitfield PC, Pickard JD. Cerebrospinal fluid dynamics. Pediatric hydrocephalus: Springer; 2005. p. 47–63. [Google Scholar]
  • 22.Henry–Feugeas M-C, Idy–Peretti I, Baledent O, Poncelet–Didon A, Zannoli G, Bittoun J, et al. Origin of subarachnoid cerebrospinal fluid pulsations: a phase-contrast MR analysis. Magn Reson Imaging. 2000;18(4):387–95. 10.1016/s0730-725x(99)00142-3 [DOI] [PubMed] [Google Scholar]
  • 23.Stoquart-ElSankari S, Balédent O, Gondry-Jouet C, Makki M, Godefroy O, Meyer M-E. Aging effects on cerebral blood and cerebrospinal fluid flows. J Cereb Blood Flow Metab. 2007;27(9):1563–72. 10.1038/sj.jcbfm.9600462 [DOI] [PubMed] [Google Scholar]
  • 24.Arbit E, Pannullo S. Lumbar stenosis: a clinical review. Clin Orthop Relat Res (1976–2007). 2001;384:137–43. [PubMed] [Google Scholar]
  • 25.Mausen JR, Heros RC. Spinal arteriovenous malformations and neurogenic claudication: report of two cases. J Neurosurg. 1988;68(5):793–7. 10.3171/jns.1988.68.5.0793 [DOI] [PubMed] [Google Scholar]
  • 26.Olmarker K, Rydevik B, Hansson T, Holm S. Compression-induced changes of the nutritional supply to the porcine cauda equina. J Spinal Disord. 1990;3(1):25–9. [PubMed] [Google Scholar]
  • 27.Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331(2):69–73. 10.1056/NEJM199407143310201 [DOI] [PubMed] [Google Scholar]
  • 28.de Graaf I, Prak A, Bierma-Zeinstra S, Thomas S, Peul W, Koes B. Diagnosis of lumbar spinal stenosis: a systematic review of the accuracy of diagnostic tests. Spine. 2006;31(10):1168–76. 10.1097/01.brs.0000216463.32136.7b [DOI] [PubMed] [Google Scholar]
  • 29.Balédent O, Idy-peretti I. Cerebrospinal fluid dynamics and relation with blood flow: a magnetic resonance study with semiautomated cerebrospinal fluid segmentation. Invest Radiol. 2001;36(7):368–77. 10.1097/00004424-200107000-00003 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Michael C Burger

12 Feb 2021

PONE-D-21-01349

Cerebrospinal fluid dynamics correlate with neurogenic claudication in lumbar spinal stenosis

PLOS ONE

Dear Dr. Kim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please adress the suggestions for improvement from the Reviewers and amend your manuscript accordingly.

Please submit your revised manuscript by Mar 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Michael C Burger, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The work presented is original and well presented, it could help clinicians working in this field.

Nevertheless some methodological points should be clarify before publication to improve the value of this paper.

Introduction : Authors should introduce previous pioneers works done on the CSF velocities in the spinal canal and discuss it

Origin of subarachnoid cerebrospinal fluid pulsations: a phase-contrast MR analysis. Magn Reson Imaging. 2000 May;18(4):387-95.

Henry-Feugeas MC et al

“Region of interest (ROI) segmentation of the spinal canal was manually performed to measure CSF dynamics within the ventral part of the dural sac. An ROI was placed within the ventral part of the dural sac, showing an evident change in CSF flow on the axial phase images. Next, the location of the ROI was adjusted by excluding the dura mater or rootlets. “

This is a crucial point of the paper; it should be interesting to see clearly the CSF ROIs obtained for the 3 cases presented in figure 1. We can see the CSF flow curves in the graph but we can’t see the Phase contrast images of the CSF flows around the spine!

Do the ROIs include all the CSF around the spine present in the slice?

Why a background of interest was not applied to avoid eddy current effects ?

It should also be important to know how many pixels were in the ROIs, what was the area of the ROIs ?

Discussion about MRI acquisition and the post processing steps is important to highlight that the measurements of the small CSF flows obtain in all the spinal canal should be interpreted with caution.

Figure 1,2,4 present CSF flow velocity. Is it the mean flow?

Please indicate on the graphs that positive values represent cephalic and negative caudal directions.

If these curves represent mean velocities of the entire CSF ROIs that mean that CSF have a net flow during the cardiac cycle. In S1 mainly in the cephalic direction whereas in S2 it is mainly in the caudal direction ! IMPOSSIBLE

If authors make the hypothesis that no net flow exist at this level and their ROIs include all the CSF around the spine, May be it should be an idea to automatically move all their CSF flow velocity curves on the Yaxis to correct the error of measurement and obtain a zero net flow. Then the results could be interpreted in a physiological way.

In the tables : simplify the numbers : example 0.7 cm/sec rather than 0.719 cm/sec unfortunately accuracy of the measurement is not so good !

Reviewer #2: This study provides an interesting look at spinal stenosis from the viewpoint of CSF dynamics that implements a PC-MRI technique to generate a more sensitive marker of neurologic claudication. The study compared CSF dynamics at the lumbosacral level between patients with LSS and healthy controls and investigated whether CSF dynamics parameters explain symptom severity in LSS. 18 healthy controls and 9 patients with LSS MRI examinations were performed.

However, the limited sample size and age distribution of cohorts that were compared severely limit the scope of analysis. In addition, the use of ANOVA and linear modeling may not be appropriate given the age distribution of the healthy group. These and other issues should be addressed to better validate use of PC-MRI in LSS.

Mayor concerns:

(1) The authors showed that there are non-negligible changes in PC-MRI measurements as a function of age; yet the LSS group is older than the control group and the control group is not normally distributed (with both young and old components). The linear models should be repeated with closer age matching, as univariate and multivariate linear models may be biased by bimodal distributions of variables.

(2) Line 141-142: The venc was selected as 4 cm/s because the CSF flow was between -2 and 2 cm/s. A reference is needed for this. Also, should different velocities be thought about in each group, if CSF dynamics are significantly altered in the LSS group?

(3) Table 2 – These velocities are measured in cross sections, so since the cross-sectional areas of the dural sac in each subject are not provided, it is not clear if this could be driving the differences seen in the velocity profiles.

(4) Line 316-317 – It can’t be said that CSF flow at the lumbar level explains the development of neurogenic claudication, but it is simply correlated with it. To explain it there has to be a definite physiological link, which, while hypothesized, has not been proven.

(5) It is stated in line 279-280 that increased CSF pressure leads to decreased metabolic exchange. Wouldn’t an increased CSF pressure be associated with higher peak amplitudes, the opposite of what is seen in this study?

(6) Table 4 – A log likelihood ratio test (LRT) would be more informative about the relative performance of each model in comparison.

(7) Should an ROC analysis be used for different models?

Other minor points:

(1) Line 43 – Define neurogenic claudication

(2) Line 45 – “Mechanical nerve root compression have been” should be “Mechanical nerve root compression has been”

(3) In Methods the authors stated that Bonferroni corrected p-values were accepted at p < 0.017, but in Tables 3 and 4 p-values were shown to be significant above this threshold. Were these p-values not subject to Bonferroni correction; explain why.

(4) Line 50 – Sentence doesn’t make sense grammatically

(5) Can you show an example of an ROI placed in the dural sac?

(6) Line 256-257 – This sentence doesn’t make sense

(7) Line 307 – Should be turbulent flow

(8) Fig 3 is intended to show that none of the CSF velocity profiles correlated with the severity of stenosis. There is no y labels for some plots.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 May 12;16(5):e0250742. doi: 10.1371/journal.pone.0250742.r002

Author response to Decision Letter 0


31 Mar 2021

The authors are grateful for the reviewers’ critical comments and the editor’s decision regarding the manuscript. We recognize the importance of the advice, and we have significantly revised the manuscript to the best of our ability.

The two reviewers shared concerns regarding the ROI segmentation of the spinal canal. Given the importance of these comments, we answer the overlapping comment first and then address the questions that were more specific. Furthermore, we also employed a professional academic editing service to correct any remaining grammar or syntax problems. We consider the revised manuscript to represent a significant improvement over the previously submitted version.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Michael C Burger

13 Apr 2021

Cerebrospinal fluid dynamics correlate with neurogenic claudication in lumbar spinal stenosis

PONE-D-21-01349R1

Dear Dr. Kim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Michael C Burger, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have done an important work to respond to the reviewers comments

the paper have largely improve and present now coherent results.

finally the authors should increase the quality of the images presented because actually the quality doesn't allow to see clearly the rois and understand where the CSF was segmented.

Reviewer #2: All my previous comments have been properly addressed. I have no other critiques and I think the article could be an interesting contribution to the field

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Michael C Burger

15 Apr 2021

PONE-D-21-01349R1

Cerebrospinal fluid dynamics correlate with neurogenic claudication in lumbar spinal stenosis

Dear Dr. Kim:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Michael C Burger

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Video. CSF flow in three typical cases: A healthy control subject (A), a healthy control subject with a narrow canal (B), and a patient with LSS (C).

    (MP4)

    S1 Fig. Scatter plots of the cross-sectional area versus CSF dynamics variables.

    (DOCX)

    S1 File. Univariate linear regression analysis to explain the claudication distance score in the elderly subjects.

    (DOCX)

    S2 File. -2 Log likelihood ratio test to determine the effect of factors on LSS.

    (DOCX)

    S3 File. ROC analysis of linear regression models to predict LSS.

    (DOCX)

    S1 Data. The relevant data about this manuscript.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES